Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
